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ABSTRACT
Hypothyroidism is a clinical syndrome due to deficiency of thyroid hormone. Thyroid hormone is responsible for maintaining the brain hemostasis 
and helps in central nervous system global development. There have been studies on the association of psychiatric illness with thyroid deficiency and 
strikingly found to be presenting feature of hypothyroidism in many patients. Literature evidence also says that underlying hypothyroidism may lead 
to failure of psychiatric treatment. Hence, we report a case of hypertensive patient on medications started with antidepressants and antipsychotics 
after being diagnosed of depression but was found to be resistant to psychiatric medications and later successfully treated with levothyroxine for 
underlying hypothyroidism with myxedema.
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INTRODUCTION
Hypothyroidism is a clinical condition characterized by a deficiency 
of thyroid hormone presenting with different manifestations ranging 
from metabolic derangements to global developmental abnormalities. 
Stereotypical cluster of symptoms includes hair loss, fatigue, dry skin, 
intolerance to cold, menstrual irregularities, and constipation. Usually, 
signs of hypothyroidism include bradycardia, facial puffiness, slow 
speech, non-pitting type of pedal edema, and delayed deep tendon 
reflexes. Psychiatric disorders are known to accompany hypothyroidism 
and diagnosis usually ranges from mild mental status impairment to 
that of severe psychosis and mood disorders [1]. Hence, we present a 
case of hypothyroidism presenting itself has depression not responding 
to psychiatric medications in a 57-year-old hypertensive male in a 
tertiary care hospital in Southern India.
CASE REPORT
Informed consent was obtained from the patient. A 57-year-old male, 
a known hypertensive on tablet amlodipine 5 mg twice daily, was 
referred from a psychiatrist in view of increased fatigue and drowsiness 
noticed for past 1 week. The patient was on tablet escitalopram 10 mg 
for depression for 3 months and tablet quetiapine 50 mg for 1 month 
for hallucinations due to psychosis. General examination revealed 
an obese male, with coarse dry skin of extremities, macroglossia, 
periorbital edema, and bipedal edema. Vital signs revealed pulse rate of 
54/min and temperature of 38°C. He was drowsy, but arousal to calling 
was present and followed simple commands but with slowness in the 
gross and fine motor activities. There were mild slurring of speech and 
delayed relaxation of the ankle jerks (Woltman’s sign). Hypothyroidism 
was suspected and thyroid-stimulating hormone levels were >100 IU, 
and serum creatine kinase levels were also markedly elevated 830 
(normal up to 80). A diagnosis of severe hypothyroidism was made, 
and levothyroxine loading dose with parenteral hydrocortisone 
was administered. Escitalopram and quetiapine were stopped. His 
symptoms improved remarkably with thyroxine replacement. His 
antidepressants and antipsychotics were discontinued and dose of 
thyroxine adjusted after repeating thyroid function tests.
DISCUSSION
Hypothyroidism and psychiatric illness have a close association and are 
said to be not infrequent. Hypothyroidism is one of the most common 
etiology overlooked for behavioral and cognitive changes in a patient. 
Forgetfulness, fatigue, mental slowness, and emotional lability are the 
most predominant symptoms, and sometimes, hypothyroid patients 
are misdiagnosed of primary psychiatric illness in the first place due 
to presenting symptoms leading to delay as well as precipitation of 
underlying thyroid illness. Depression is the most common affective 
disorder seen in hypothyroid patients [2]. The brain tends to use thyroid 
hormone very differently when compared to other organs in the body, 
and thyroid hormone is required for the development of central nervous 
system as well as maintenance of hemostasis. T3 receptors are present 
in high concentrations in the hippocampus and amygdala influencing 
the neural activity. T4 hormone exerts its neurobehavioral action 
through an effect on various neurotransmitters. In a study, it was found 
that hypothyroid rats were found to have increased amount of tyrosine 
hydroxylase activity and increased dopamine levels in comparison to 
hyperthyroid rats [3-5]. Incidence of psychotic disorders associated 
with hypothyroidism ranges from 5 to 15% with traditionally patients 
presenting with lassitude and lethargy as in initial manifestation [6]. 
Depression being the most common affective disorder associated with 
hypothyroidism, the incidence of depression associated with clinical 
hypothyroidism is 40% [7]. Although the incidence of depression with 
subclinical hypothyroidism is not known, refractory depression is 
known to be very common in patients with subclinical hypothyroidism 
with incidences ranging up to 50% [8]. Treatment-resistant depression 
usually responds to thyroid supplementation with or without laboratory 
investigation revealing altered thyroid status. Various theories have 
been proposed on the association of depression with hypothyroidism. 
Main and foremost one is the involvement of serotonergic system, and 
it has been found that reduced levels of serotonin were found in the 
brain in case of hypothyroidism [9]. Other hypotheses include reduced 
or inhibited activity of Type 2 5’deiodinase enzyme leading to reduced 
conversion of T4 to T3 in the brain and depression is related to brain 
catecholamine deficiency in hypothyroid patients [9].
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The treatment is usually replacement of thyroid hormone and psychiatric 
disturbances usually get corrected as the endocrinopathy is corrected. 
The use of antidepressants is usually sought only after correcting the 
thyroid status. Moreover, the use of quetiapine can aggravate a pre-
existing overt severe hypothyroidism and precipitate into a myxedema 
coma. The risk of quetiapine per day causing hypothyroidism is 
about 0.4% with about half of them requiring thyroid replacement 
therapy [10]. In this case, after diagnosing the patient with depression, 
he was started with antidepressants along with antipsychotics. 
However, the patient never responded. Other signs and symptoms 
suggestive of underlying hypothyroidism with myxedema coma. Hence, 
levothyroxine and corticosteroids were started, and antidepressants 
and antipsychotics were stopped. The patient improved after 2 weeks.
CONCLUSIONS
This patient presented with severe myxedema and pre-coma like 
features. The depression was secondary to hypothyroidism and could 
have been treated effectively if thyroid function tests were obtained 
before starting antidepressant medications. Moreover, addition of 
quetiapine and escitalopram precipitated and accelerated the rate 
of progression of hypothyroidism. Myxedema coma is a medical 
emergency and can be fatal if not diagnosed early and treated effectively. 
Prompt recognition of the near fatal myxedema and early initiation of 
thyroxine resulted in effective “cure” of his depression.
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